BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27179602)

  • 1. Fatty acid composition in serum correlates with that in the liver and non-alcoholic fatty liver disease activity scores in mice fed a high-fat diet.
    Wang XH; Li CY; Muhammad I; Zhang XY
    Environ Toxicol Pharmacol; 2016 Jun; 44():140-50. PubMed ID: 27179602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
    Liu J; Han L; Zhu L; Yu Y
    Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver Disease.
    Fengler VH; Macheiner T; Kessler SM; Czepukojc B; Gemperlein K; Müller R; Kiemer AK; Magnes C; Haybaeck J; Lackner C; Sargsyan K
    PLoS One; 2016; 11(5):e0155163. PubMed ID: 27167736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
    Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
    J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternation of plasma fatty acids composition and desaturase activities in children with liver steatosis.
    Hua MC; Su HM; Yao TC; Kuo ML; Lai MW; Tsai MH; Huang JL
    PLoS One; 2017; 12(7):e0182277. PubMed ID: 28759573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenously synthesized n-3 polyunsaturated fatty acids in fat-1 mice ameliorate high-fat diet-induced non-alcoholic fatty liver disease.
    Kim EH; Bae JS; Hahm KB; Cha JY
    Biochem Pharmacol; 2012 Nov; 84(10):1359-65. PubMed ID: 22981383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Lipidomic Readout of Disease Progression in A Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease.
    Sanyal AJ; Pacana T
    Trans Am Clin Climatol Assoc; 2015; 126():271-88. PubMed ID: 26330688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota-mediated generation of saturated fatty acids elicits inflammation in the liver in murine high-fat diet-induced steatohepatitis.
    Yamada S; Kamada N; Amiya T; Nakamoto N; Nakaoka T; Kimura M; Saito Y; Ejima C; Kanai T; Saito H
    BMC Gastroenterol; 2017 Nov; 17(1):136. PubMed ID: 29187142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling.
    Deng X; Wang J; Jiao L; Utaipan T; Tuma-Kellner S; Schmitz G; Liebisch G; Stremmel W; Chamulitrat W
    Biochim Biophys Acta; 2016 May; 1861(5):449-61. PubMed ID: 26873633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal study of circulating miR-122 in a rat model of non-alcoholic fatty liver disease.
    Yamada H; Ohashi K; Suzuki K; Munetsuna E; Ando Y; Yamazaki M; Ishikawa H; Ichino N; Teradaira R; Hashimoto S
    Clin Chim Acta; 2015 Jun; 446():267-71. PubMed ID: 25958847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
    Kim S; Hong J; Jeon R; Kim HS
    Nutr Res; 2016 Jan; 36(1):90-100. PubMed ID: 26773785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of high-fat high-fructose diet treatment in factor VIII (coagulation factor)-deficient mouse model.
    Mishra A; Arindkar S; Sahay P; Kumar JM; Upadhyay PK; Majumdar SS; Nagarajan P
    Int J Exp Pathol; 2018 Feb; 99(1):46-53. PubMed ID: 29656466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esculetin prevents non-alcoholic fatty liver in diabetic mice fed high-fat diet.
    Choi RY; Ham JR; Lee MK
    Chem Biol Interact; 2016 Dec; 260():13-21. PubMed ID: 27769711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of heat-treated Enterococcus faecalis FK-23 on high-fat diet-induced hepatic steatosis in mice.
    Kondoh M; Shimada T; Fukada K; Morita M; Katada K; Higashimura Y; Mizushima K; Okamori M; Naito Y; Yoshikawa T
    Br J Nutr; 2014 Sep; 112(6):868-75. PubMed ID: 25089585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exendin‑4, a glucagon‑like peptide‑1 receptor agonist, modulates hepatic fatty acid composition and Δ‑5‑desaturase index in a murine model of non‑alcoholic steatohepatitis.
    Kawaguchi T; Itou M; Taniguchi E; Sata M
    Int J Mol Med; 2014 Sep; 34(3):782-7. PubMed ID: 24993337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis.
    Yamada K; Mizukoshi E; Sunagozaka H; Arai K; Yamashita T; Takeshita Y; Misu H; Takamura T; Kitamura S; Zen Y; Nakanuma Y; Honda M; Kaneko S
    Liver Int; 2015 Feb; 35(2):582-90. PubMed ID: 25219574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dietary fatty acids and cholesterol excess on liver injury: A lipidomic approach.
    Serviddio G; Bellanti F; Villani R; Tamborra R; Zerbinati C; Blonda M; Ciacciarelli M; Poli G; Vendemiale G; Iuliano L
    Redox Biol; 2016 Oct; 9():296-305. PubMed ID: 27639112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of eNOS exacerbates early-stage NAFLD pathogenesis by changing the fat distribution.
    Nozaki Y; Fujita K; Wada K; Yoneda M; Shinohara Y; Imajo K; Ogawa Y; Kessoku T; Nakamuta M; Saito S; Masaki N; Nagashima Y; Terauchi Y; Nakajima A
    BMC Gastroenterol; 2015 Dec; 15():177. PubMed ID: 26678309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.